A multicenter real-life study provides new insights into acquired hemophilia, highlighting its prevalence and management in a middle-income country. The findings may inform future treatment strategies and improve patient outcomes.

A recent case report highlights the complexities of acquired hemophilia A, detailing instances of hematoma, hemarthrosis, and hemotympanum. This study contributes to the understanding of the clinical manifestations associated with this rare bleeding disorder.

A recent cost-effectiveness analysis evaluates the use of emicizumab in hospitalized older patients with acquired hemophilia A. The study provides insights into the economic implications of this treatment option for a vulnerable patient population.